🔎 Trials Near Me

Dachaigh › Aillse sa bhlaire › California › San Francisco

Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an San Francisco, CA

Tha 13 sgrùdaidhean airson Aillse sa bhlaire a’ lorg phàirtichean aig làraichean ann agus timcheall air San Francisco (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

A’ fastadhÌre 1/2
  • UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07232602

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

A’ fastadhÌre 1
  • University of California, San Francisco, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07664397

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

A’ fastadhÌre 1/2
  • University of California, San Francisco, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06470282

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

A’ fastadhÌre 3
  • UCSF Medical Center at Mission Bay, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

A’ fastadhÌre 1
  • UCSF Medical center Parnassus, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07217171

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

A’ fastadhÌre 2/3
  • Pacific Hematology Oncology Associates, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

A’ fastadhÌre 2
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

A’ fastadhÌre 3
  • Research Site, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

A’ fastadhÌre 2
  • UCSF Cancer Center MZ Phlebotomy, San Francisco
  • UCSF Mount Zion Phlebotomy, San Francisco
  • UCSF Parnassus Phlebotomy, San Francisco
  • agus 3 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT04879329

Predicting BCG Response

A’ fastadhSgrùdadh amharc
  • UCSF, San Francisco
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04564781

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

A’ fastadhÌre 1
  • University of California San Francisco, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT06778863

Blue Light Cystoscopy With Cysview® Registry

A’ fastadhSgrùdadh amharc
  • University of California, San Francisco, San Francisco
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Dùbh 2025 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, San Francisco
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile

Sgrùdaidhean eile ann an San Francisco

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.